Cannabix has developed a
contactless alcohol breathalyzer for employers and vehicles
VANCOUVER, British Columbia, Canada -- November 7, 2023 --
InvestorsHub NewsWire -- Cannabix Technologies Inc. (CSE:
BLO) (OTC
PINK: BLOZF) (the "Company or Cannabix") developer of breath
testing devices for law enforcement and the workplace reports that
it has completed preliminary third-party testing on its Contactless
Alcohol Breathalyzer ("CAB") wall mounted device (new device photos
below). The Company is nearing completion of its first commercial
version of its CAB device and has conducted electronics testing in
October at QAI Laboratories ("QAI") in British Columbia, an
accredited lab recognized in the U.S and Canada for its electrical
safety evaluations and certification. In particular, engineers
successfully completed preliminary electromagnetic compatibility
(EMC), emissions, immunity testing and vibration testing at QAI
with the Cannabix CAB device. The CAB workplace series (industrial
version) is now being prepared for international alcohol standards
testing.
NEW CAB Workplace Series (Industrial
version)
The Company is completing its first CAB technology for
workplaces, an industrial weather resistant version (see Figure 1)
with many features including an innovative pre-calibrated modular
cartridge technology. Cannabix commenced pilot testing of its work
series CAB with the Montana based, Friedel Clinic, in March 2023
and the device has performed well with over 700 breath samples
taken thus far. The CAB device is part of the Company's portfolio
of marijuana and alcohol screening devices. The Company will be
selecting a new product name for the CAB and create new product
branding in the coming weeks.
Figure 1. Cannabix Contactless
Alcohol Breathalyzer (CAB) Workplace Series - Industrial
Version
Cannabix is covering two significant threats to workplace safety
with its alcohol and marijuana breath screening technologies. An
increasing number of employers are taking proactive measures to
safeguard their workers and their operations by implementing
alcohol testing procedures. Workplace testing instances typically
include random testing, start-of-shift testing, pre-employment
testing, return-to-work testing, post-incident testing, reasonable
cause testing, and pre-promotion testing. The wall mounted CAB
would be targeted for all of the above testing instances, and will
be especially effective with pre-access alcohol testing before and
during work hours.
Targeted Solution for Employers and
Organizations
The CAB automatically checks the sobriety of employees when they
come to work (easily installed at select access points), allowing
for fast breath sampling in both contactless and straw mode. The
device takes a picture while a breath sample is being delivered to
confirm and record identity and allows for quick input of an
employee identification code for system logging. Upon detection of
alcohol on the breath, the CAB will deliver a precise Blood Alcohol
Content (BAC) level on the screen, as well as sending real-time
alerts via text message, e-mail and dedicated portal about the
positive sample. Furthermore, the system logs user testing for
incident reporting and historical investigations.
The Company has received interest from the U.S. and Australia
for the commercialization of the CAB. Cannabix is consulting with
an established distributor and vendor of alcohol devices in
Australia and will be opening up distribution relationships with
alcohol device vendors in the United States.
Cannabix will be targeting the CAB for small to medium sized
enterprises (SME's), in a range of industries like construction,
production, oil and gas, mining, agriculture, forestry sectors and
warehousing and transport industry.
24/7 Sobriety Program in the United States
More recently the Company has been examining the use of the CAB
as a new solution for the 24/7 Sobriety
Program existing in several states in the U.S. This
program seeks to reduce the re-arrests of individuals previously
convicted of driving while under the influence (DUI) of alcohol or
drugs through daily breath testing.
In a 24/7 sobriety program, offenders are
scheduled for twice daily alcohol testing at select locations in a
given state or county. Currently the 24/7 program requires
dedicated employees to administer alcohol tests with a handheld
alcohol breathalyzer throughout the day. The Cannabix CAB could
revolutionize the program with completely autonomous CAB devices
collecting and reporting breath tests of the 24/7 sobriety program
to state and local officials at a lower cost, leading to
potentially significant savings and efficiency.
CAB Features
A robust feature set for the CAB includes contactless and direct
breath testing, photo identity confirmation, time and attendance,
Wi-Fi connectivity, RFID log-in.
A live data management portal for managers seeking real-time BAC
results via the text and email has been developed. This data
management system uses best in class Amazon Web Services
(AWS) for its cloud-based infrastructure and
security.
New Innovation - CAB Pre-Calibrated Alcohol Sensor
Cartridges
The Company has developed an innovative pre-calibrated modular
cartridge technology that will allow organizations to quickly and
easily maintain their CAB devices. This new technology holds the
potential to transform a host of existing technologies which reply
upon costly calibration equipment and time-consuming site visits
from technicians for maintenance. The Cannabix cartridge technology
provides a way for customers and distributors to replace cartridges
to maintain calibration. Furthermore, this hardware provides an
opportunity for recurring revenue stream from installations (See
Figure 1).
About Cannabix Technologies Inc.
Cannabix Technologies Inc. is a developer of marijuana and
alcohol breathalyzer technologies for law enforcement, workplaces
and laboratories. Cannabix is developing delta-9 THC and alcohol
screening devices. Delta-9 THC is the psychoactive component of
marijuana that causes impairment. Breath testing for delta-9 THC
would allow employers and law enforcement to identify recent
marijuana use. Cannabix is the developer of contactless
breath alcohol detection devices for employers and a
range of other settings.
We seek Safe Harbor.
On behalf of the Board of Directors
"Rav Mlait"
CEO
Cannabix Technologies Inc.
For further information, contact the Company
at info@cannabixtechnologies.com
The CSE has not reviewed and does not accept responsibility
for the adequacy or accuracy of this release.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking information that
involves various risks and uncertainties regarding future events.
Such forward-looking information can include without limitation
statements based on current expectations involving a number of
risks and uncertainties and are not guarantees of future
performance of the Company, such as final development of a
commercial or prototype product(s), successful trial or pilot of
company technologies, no assurance that commercial sales of any
kind actually materialize; no assurance the Company will have
sufficient funds to complete product development. There are
numerous risks and uncertainties that could cause actual results
and the Company's plans and objectives to differ materially from
those expressed in the forward-looking information, including: (i)
adverse market conditions; (ii) risks regarding protection of
proprietary technology; (iii) the ability of the Company to
complete financings; (iv) the ability of the Company to develop and
market its future product; and (v) risks regarding government
regulation, managing and maintaining growth, the effect of adverse
publicity, litigation, competition and other factors which may be
identified from time to time in the Company's public announcements
and filings. There is no assurance that its development of
breathalyzer technology will provide any benefit to the Company,
and no assurance that any proposed new products will be built, will
be successful in beta testing or clinical trials. The is no
assurance that the Company will enter into any partnerships to
advance any of its corporate initiatives or technologies. There is
no assurance that any "patent pending" or "provisional patents"
technologies licensed by the Company or owned by the Company will
receive patent status by regulatory authorities. The Company is not
currently selling commercial breathalyzers. Actual results and
future events could differ materially from those anticipated in
such information. These and all subsequent written and oral
forward-looking information are based on estimates and opinions of
management on the dates they are made and are expressly qualified
in their entirety by this notice. Except as required by law, the
Company does not intend to update these forward-looking
statements.
Cannabix Technologies (CSE:BLO)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Cannabix Technologies (CSE:BLO)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024
